Innate Pharma announces today the outcome of its annual general meeting, including changes in the composition of its Supervisory Board

  • Innate Pharma held its annual general meeting on June 23, 2009
  • All proposed resolutions were voted according to management’s recommendations
  • Mrs. Irina Staatz-Granzer joins the Supervisory Board as a new, independent member
  • Mr. Patrick Van Beneden, from GIMV, an investor, is appointed as observer to the Supervisory Board for a one-year period
PR in english 40.67 KB
CP en français 41.75 KB